Literature DB >> 2997183

The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells.

G Neufeld, D Gospodarowicz.   

Abstract

The binding of biologically active, 125I-labeled basic fibroblast growth factor (FGF) to baby hamster kidney-derived cell line cells (BHK-21) was studied at 4 degrees C. Unlabeled FGF displaced cell surface bound 125I-FGF, but platelet-derived growth factor, epidermal growth factor, insulin, or transferrin did not. Binding was saturable both as a function of time and as a function of increasing 125I-FGF concentrations. Scatchard analysis of the binding data revealed the presence of about 1.2 X 10(5) binding sites/cell with an apparent KD of 270 pM. The number of the binding sites was down-regulated following preincubation of the cells with FGF. The density of binding sites/cell also decreased as an inverse function of cell density. When 125I-FGF binding was studied in a BHK-21 cell membrane preparation, it was found that the membranal binding site displayed a lower KD of 21 pM. 125I-FGF was covalently cross-linked to its cell surface receptor on intact BHK-21 cells using the homobifunctional agent disuccinimidyl suberate. Two macromolecular species with an apparent molecular weight of 145,000 and 125,000, respectively, were labeled under both reducing and nonreducing conditions. Unlabeled FGF competed with 125I-FGF for binding to both macromolecular species. The labeling of the macromolecules was also inhibited by heparin. No labeling was observed in the absence of the cross-linkers or when heat-inactivated 125I-FGF was used instead of radiolabeled, biologically active FGF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997183

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Heparin-binding growth factors and their receptors.

Authors:  B B Olwin
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  A modified chorioallantoic membrane (CAM) assay for qualitative and quantitative study of growth factors. Studies on the effects of carriers, PBS, angiogenin, and bFGF.

Authors:  J Wilting; B Christ; M Bokeloh
Journal:  Anat Embryol (Berl)       Date:  1991

3.  Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells.

Authors:  L Schweigerer; G Neufeld; D Gospodarowicz
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

4.  Characterization of release of basic fibroblast growth factor from bovine retinal endothelial cells in monolayer cultures.

Authors:  R A Brooks; J M Burrin; E M Kohner
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

5.  Specific binding of angiogenin to calf pulmonary artery endothelial cells.

Authors:  J Badet; F Soncin; J D Guitton; O Lamare; T Cartwright; D Barritault
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.

Authors:  T A Tetzke; M C Caton; P A Maher; Z Parandoosh
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

7.  Isolation, characterization, and localization of heparin-binding growth factors in the heart.

Authors:  W Casscells; E Speir; J Sasse; M Klagsbrun; P Allen; M Lee; B Calvo; M Chiba; L Haggroth; J Folkman
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

8.  Vascular growth factor binding kinetics to the endothelial cell basement membrane, with a kinetics-based correction for substrate binding.

Authors:  Alisa Morss Clyne; Elazer R Edelman
Journal:  Cytotechnology       Date:  2009-07-29       Impact factor: 2.058

9.  Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor.

Authors:  M C Kiefer; J C Stephans; K Crawford; K Okino; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

10.  A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity.

Authors:  A Isacchi; M Statuto; R Chiesa; L Bergonzoni; M Rusnati; P Sarmientos; G Ragnotti; M Presta
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.